These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

215 related items for PubMed ID: 22543828

  • 41. High-dose therapy and autologous blood stem-cell transplantation compared with conventional treatment in myeloma patients aged 55 to 65 years: long-term results of a randomized control trial from the Group Myelome-Autogreffe.
    Fermand JP, Katsahian S, Divine M, Leblond V, Dreyfus F, Macro M, Arnulf B, Royer B, Mariette X, Pertuiset E, Belanger C, Janvier M, Chevret S, Brouet JC, Ravaud P, Group Myelome-Autogreffe.
    J Clin Oncol; 2005 Dec 20; 23(36):9227-33. PubMed ID: 16275936
    [Abstract] [Full Text] [Related]

  • 42. Successful hematopoietic stem-cell transplantation in multicentric Castleman disease complicated by POEMS syndrome.
    Ganti AK, Pipinos I, Culcea E, Armitage JO, Tarantolo S.
    Am J Hematol; 2005 Jul 20; 79(3):206-10. PubMed ID: 15981232
    [Abstract] [Full Text] [Related]

  • 43. The first 2 years of clinical experience with peripheral blood stem cell transplantation for various hematological malignancies: results from a single Baskent University Center.
    Ozdogu H, Boga C, Kizilkilic E, Kozanoglu I, Karakus S, Sahin FI, Unalan D, Haberal M.
    Transplant Proc; 2007 May 20; 39(4):1257-60. PubMed ID: 17524948
    [Abstract] [Full Text] [Related]

  • 44. Combination of melphalan and dexamethasone for patients with newly diagnosed POEMS syndrome.
    Li J, Zhang W, Jiao L, Duan MH, Guan HZ, Zhu WG, Tian Z, Zhou DB.
    Blood; 2011 Jun 16; 117(24):6445-9. PubMed ID: 21393478
    [Abstract] [Full Text] [Related]

  • 45. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
    Adam Z, Krejcí M, Pour L, Stepánková S, Cermáková Z, Voska L, Teplan V, Krivanová A, Hájek R, Mayer J.
    Vnitr Lek; 2009 Nov 16; 55(11):1089-96. PubMed ID: 20017442
    [Abstract] [Full Text] [Related]

  • 46. Feasibility and outcome of tandem stem cell autotransplants in multiple myeloma.
    Galli M, Nicolucci A, Valentini M, Belfiglio M, Delaini F, Crippa C, Barbui AM, Giussani U, Rambaldi A, Barbui T.
    Haematologica; 2005 Dec 16; 90(12):1643-9. PubMed ID: 16330437
    [Abstract] [Full Text] [Related]

  • 47. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis.
    Jaccard A, Moreau P, Leblond V, Leleu X, Benboubker L, Hermine O, Recher C, Asli B, Lioure B, Royer B, Jardin F, Bridoux F, Grosbois B, Jaubert J, Piette JC, Ronco P, Quet F, Cogne M, Fermand JP, Myélome Autogreffe (MAG) and Intergroupe Francophone du Myélome (IFM) Intergroup.
    N Engl J Med; 2007 Sep 13; 357(11):1083-93. PubMed ID: 17855669
    [Abstract] [Full Text] [Related]

  • 48. [High-dose chemotherapy and autologous stem cell transplantation in multiple myeloma patients--single center experience].
    Piatkowska-Jakubas B, Wolska-Smoleń T, Mensah-Glanowska P, Hawrylecka D, Szostek M, Walter Z, Skotnicki AB.
    Przegl Lek; 2011 Sep 13; 68(2):78-81. PubMed ID: 21751514
    [Abstract] [Full Text] [Related]

  • 49. High-dose melphalan with autologous hematopoietic stem cell transplantation for acute myeloid leukemia: results of a retrospective analysis of the Italian Pediatric Group for Bone Marrow Transplantation.
    Cesaro S, Meloni G, Messina C, Pillon M, Proglia A, Lanino E, Caniggia M, Bagnulo S, Pession A, Locatelli F, Italian Pediatric Group for Bone Marrow Transplantation.
    Bone Marrow Transplant; 2001 Jul 13; 28(2):131-6. PubMed ID: 11509930
    [Abstract] [Full Text] [Related]

  • 50. High-dose therapy and autologous peripheral blood stem cells transplantation followed by a very low reduced intensity regimen with fludarabine + cyclophosphamide and allograft improve complete remission rate in de novo multiple myeloma patients.
    Martino M, Console G, Irrera G, Praticò G, Stelitano C, Callea V, Morabito F, Quartarone E, Musolino C, Piro E, Brugiatelli M, Iacopino P.
    Am J Hematol; 2006 Dec 13; 81(12):973-8. PubMed ID: 16888786
    [Abstract] [Full Text] [Related]

  • 51. POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy and skin changes) treated with autologous hematopoietic stem cell transplantation: a case report and literature review.
    Arana C, Pérez de León JA, Gómez-Moreno G, Pérez-Cano R, Martín Hernández T.
    Am J Case Rep; 2015 Mar 01; 16():124-9. PubMed ID: 25726020
    [Abstract] [Full Text] [Related]

  • 52. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial.
    Cohen AD, Zhou P, Chou J, Teruya-Feldstein J, Reich L, Hassoun H, Levine B, Filippa DA, Riedel E, Kewalramani T, Stubblefield MD, Fleisher M, Nimer S, Comenzo RL.
    Br J Haematol; 2007 Oct 01; 139(2):224-33. PubMed ID: 17897298
    [Abstract] [Full Text] [Related]

  • 53. Primary AL amyloid polyneuropathy successfully treated with high-dose melphalan followed by autologous stem cell transplantation.
    Katoh N, Matsuda M, Yoshida T, Yazaki M, Morita H, Sakashita K, Ikeda S.
    Muscle Nerve; 2010 Jan 01; 41(1):138-43. PubMed ID: 19813189
    [Abstract] [Full Text] [Related]

  • 54. Thalidomide reduces serum VEGF levels and improves peripheral neuropathy in POEMS syndrome.
    Kuwabara S, Misawa S, Kanai K, Sawai S, Hattori T, Nishimura M, Nakaseko C.
    J Neurol Neurosurg Psychiatry; 2008 Nov 01; 79(11):1255-7. PubMed ID: 18469028
    [Abstract] [Full Text] [Related]

  • 55. Dramatic improvement of POEMS syndrome following autologous haematopoietic cell transplantation.
    Rovira M, Carreras E, Bladé J, Graus F, Valls J, Fernández-Avilés F, Montserrat E.
    Br J Haematol; 2001 Nov 01; 115(2):373-5. PubMed ID: 11703338
    [Abstract] [Full Text] [Related]

  • 56. "Short course" bortezomib plus melphalan and prednisone as induction prior to transplant or as frontline therapy for nontransplant candidates in patients with previously untreated multiple myeloma.
    Gasparetto C, Gockerman JP, Diehl LF, de Castro CM, Moore JO, Long GD, Horwitz ME, Keogh G, Chute JP, Sullivan KM, Neuwirth R, Davis PH, Sutton LM, Anderson RD, Chao NJ, Rizzieri D.
    Biol Blood Marrow Transplant; 2010 Jan 01; 16(1):70-7. PubMed ID: 19733251
    [Abstract] [Full Text] [Related]

  • 57. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.
    Re A, Cattaneo C, Michieli M, Casari S, Spina M, Rupolo M, Allione B, Nosari A, Schiantarelli C, Vigano M, Izzi I, Ferremi P, Lanfranchi A, Mazzuccato M, Carosi G, Tirelli U, Rossi G.
    J Clin Oncol; 2003 Dec 01; 21(23):4423-7. PubMed ID: 14581441
    [Abstract] [Full Text] [Related]

  • 58. Role for high-dose therapy with autologous hematopoietic stem cell support in Waldenstrom's macroglobulinemia.
    Munshi NC, Barlogie B.
    Semin Oncol; 2003 Apr 01; 30(2):282-5. PubMed ID: 12720153
    [Abstract] [Full Text] [Related]

  • 59. High-dose melphalan and auto-SCT in patients with monoclonal Ig deposition disease.
    Hassoun H, Flombaum C, D'Agati VD, Rafferty BT, Cohen A, Klimek VM, Boruchov A, Kewalramani T, Reich L, Nimer SD, Comenzo RL.
    Bone Marrow Transplant; 2008 Sep 01; 42(6):405-12. PubMed ID: 18574442
    [Abstract] [Full Text] [Related]

  • 60. High-dose therapy and autologous blood stem cell transplantation in POEMS syndrome.
    Jaccard A, Royer B, Bordessoule D, Brouet JC, Fermand JP.
    Blood; 2002 Apr 15; 99(8):3057-9. PubMed ID: 11929800
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.